Glenmark Pharma inks settlement pact with Pfizer for cancer drug
Glenmark’s product is the generic version of Pfizer’s Inlyta tablets, used to treat kidney cancer. File | Photo Credit: The Hindu Glenmark Pharmaceuticals on Tuesday said it has entered into a settlement agreement with Pfizer Inc. regarding a cancer treatment drug. The Mumbai-based drug maker and its U.S.-based unit have inked a settlement pact with […]
Continue Reading
